Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors.

MLA

Patel, Akash J., et al. “Molecular Profiling Predicts Meningioma Recurrence and Reveals Loss of DREAM Complex Repression in Aggressive Tumors.” Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 43, Oct. 2019, pp. 21715–26. EBSCOhost, https://doi.org/10.1073/pnas.1912858116.

APA

Patel, A. J., Wan, Y.-W., Al-Ouran, R., Revelli, J.-P., Cardenas, M. F., Oneissi, M., Xi, L., Jalali, A., Magnotti, J. F., Muzny, D. M., Doddapaneni, H., Sebastian, S., Heck, K. A., Goodman, J. C., Gopinath, S. P., Liu, Z., Rao, G., Plon, S. E., Yoshor, D., … Klisch, T. J. (2019). Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proceedings of the National Academy of Sciences of the United States of America, 116(43), 21715–21726. https://doi.org/10.1073/pnas.1912858116

Chicago

Patel, Akash J, Ying-Wooi Wan, Rami Al-Ouran, Jean-Pierre Revelli, Maria F Cardenas, Mazen Oneissi, Liu Xi, et al. 2019. “Molecular Profiling Predicts Meningioma Recurrence and Reveals Loss of DREAM Complex Repression in Aggressive Tumors.” Proceedings of the National Academy of Sciences of the United States of America 116 (43): 21715–26. doi:10.1073/pnas.1912858116.